Researchers are excited about this new drug, a innovative dual agonist showing significant results in initial trials for body reduction . It works by targeting two hormones : GLP-1 and GIP, these, when engaged , assist regulate cravings and enhance metabolism . Preliminary observations demonstrate substantial size loss and possible advantages for p